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Background:  Needle Aspiration Cytology (FNAC) is cheap, simple, quick, minimally 
invasive procedure that is widely used for preoperative diagnosis of Parotid tumours. 
Methods: Twenty five patients were prospectively studied over a two-year period at four 
major hospitals in Zambia. FNAC was done using a 10cc syringe and 20-22G needles for 
sample collection and specimen staining was done with papanicolaou stain. 
Histopathology was assessed with Haematoxylin and Eosin (H&E) stained sections. 
Results: FNAC correlated with histopathology with a sensitivity of 100% and specificity of 
66.7%; positive and negative predictive values of 95.7% and 100% respectively and a 
likelihood ratio of 3. All Parotid tumours were neoplastic with 76% benign and 24% 
malignant tumours on histopathology. FNAC accurately diagnosed 68% benign and 20% 
malignant tumours.   
Conclusion: This study found that FNAC correlates well with histopathology in the 
diagnosis of parotid tumours. FNAC is useful in the preoperative assessment of Parotid 
tumours as it provides a preoperative diagnosis that influences management by either 
avoiding surgery (inflammatory lesion) and limiting the extent of surgery for benign and 
malignant Parotid tumours. 
 
Introduction 
George Papanicolaou (1883-1962) is generally accredited for use of cytopathological 
examination of cells for diagnosis of tumours. FNAC involves subjecting appropriately 
stained aspirated cells to cytopathological examination where the cells are evaluated for 
morphological changes based on the appearance of individual cells or cell clusters⁹. 
Theoretically this procedure is supposed to diagnose most tumours with acceptable 




ISSN 2073-9990   East Cent. Afr. J. surg  
 
COSECSA/ASEA Publication --East & Central African Journal of Surgery 2017; Vol. 22 (1) 
 
Salivary gland tumours make up 10% of all head and neck tumours (parotid gland tumours 
contribute 2-6.5%) and 3% of all tumours of the body4, 9, 10, 11. There are two types of Salivary 
glands, major (parotid, submandibular and lingual) and minor salivary glands1. The parotid 
gland tumours are 10 times more common than submandibular tumours and 100 times 
more common than lingual tumours. 80% of parotid tumours are benign1.  
 
The incidence of parotid gland tumours is 1-2/100,000 1. There is equal incidence between 
the sexes1. Risk factors for development of parotid gland tumours include nutritional 
deficiencies, exposure to radiation, ultra-violet exposure, genetic predisposition and 
infection with Epstein-Barr virus1.  
 
Generally, it has been accepted among Head and Neck Surgeons that tumours of the parotid 
gland, present management problems for various reasons4, 11. In the first instance, most 
surgeons believe that the presence of a parotid gland tumour is an indication for 
removal4,9,11. Clinical diagnosis has been used to preoperatively diagnose and influence 
surgical management of a patient with a parotid gland tumour. But it is difficult to 
distinguish clinically between inflammatory and non-inflammatory lesions or between 
benign and malignant lesions1. This is because inflammatory lesions are not subjected to 
surgery but conservative management1, 4, 9. Clinical diagnosis has resulted in over treatment 
of patients with inflammatory parotid tumours which have been subjected to surgery and 
under treatment of patients with malignant parotid lesions that have been treated by 
parotid conserving surgery4,9,11. Clinical diagnosis cannot decide the fate of the facial nerve, 
whether to excise or not, excision of facial nerve with its consequence of facial nerve 
paralysis has resulted in increased morbidity1,4,9,11.   
 
It remains a challenge to obtain a preoperative tissue diagnosis of the parotid gland tumour 
because salivary gland tumours are not subject to conventional tissue diagnosis by core 
needle biopsy or incisional biopsy as these complicate into formation of salivary fistulae and 
implantation of malignant tumours1, 4, 9, 10, 11,12. Secondly, a preoperative diagnosis ensures 
planning of the surgical procedure to be done (whether conservative or total parotidectomy 
and whether to do neck dissection or not in the case of malignant tumours)1, 4, 9, 10, 11, 12. 
However, lack of a preoperative diagnosis poses a challenge to appropriately counsel 
patients about the preoperative diagnosis and prognosis and what procedure is to be done 
and whether or not the facial nerve will be preserved4.  
 
Thirdly, an intraoperative diagnosis at the time of surgery by assessment of frozen sections 
is not readily available even in developed centres and they are not available in resource 
limited centres especially in the developing world like Zambia4,9,12. 
 
In view of the above, FNAC has gained popularity among Head and Neck surgeons who have 
used this procedure to preoperatively diagnose Head and Neck Tumours4, 9. The application 
of FNAC for diagnosis of Parotid gland tumors has been an area that has been widely 
debated4, 5, 9,  10, 11. The management problems of patients with parotid gland tumours has 
led to more research being done about the application of FNAC in obtaining a preoperative 
tissue diagnosis4. As a result, FNAC has established its role in the diagnosis of parotid gland 
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tumours1, 4, 5, 8, 9, 10, 11, 12. Those who support FNAC use in the preoperative diagnosis argue 
that FNAC can distinguish neoplastic from non-neoplastic lesions, and benign from 
malignant tumours; and incidence of complications with FNAC is rare4, 6, 9, 10, 11, 12. 
 
Those who argue against the use of FNAC in the diagnosis of parotid gland tumours feel that 
FNAC has low sensitivity in the diagnosis of parotid gland malignant tumours, and that it 
only changes the management of lymphomas of the parotid gland4, 18. They argue that FNAC 
obscures diagnosis, there is increased incidence of inadequate sampling therefore, it 
requires multiple sampling, prolongs the period of waiting for operative management and 
therefore increases the cost of hospital stay18. The Value of FNAC in the investigation of 
salivary gland disease has also been widely discussed by both Clinicians and 
Cytopathologists4, 9, 10, 11. Most Clinicians argue that FNAC is not accurate enough to 
diagnose parotid gland tumours and therefore influence decision making in terms of 
whether to operate or not to operate4, 12. 
 
An audit of the parotid gland surgeries was performed at University Teaching Hospital (UTH) 
between August 2013 and September 2014. A total of 14 parotid gland surgeries were done 
for parotid gland tumours. 79% were superficial Parotidectomies and 21% were total 
Parotidectomies. None of the patients had a preoperative tissue diagnosis to objectively 
ascertain the extent of the surgery in order to avoid over or under treatment. Only 14% had 
a post-operative diagnosis the rest had missing excised parotid samples, either they were 
taken to other laboratories or the samples were lost. It cannot be objectively stated 
whether we are treating our patients optimally or not from the above statistics. In this era 
of patients being aware about their rights, this is a recipe for litigation because the 
consequences of not optimally treating patients are grave. This is the more reason why we 
need to conduct our own studies on how we can achieve a preoperative diagnosis of the 
parotid gland tumours and determine whether surgical intervention is required or not and if 
it is required then to what extent should it be done. In short we need to practice evidence 
based medicine. 
 
This study was aimed at evaluating the diagnostic accuracy of FNAC of parotid gland 
tumours by correlating it with Histopathological diagnosis. At the time of operation and with 
obtained informed consent, an FNAC sample of the parotid gland tumour planned for 
excision was obtained while the patient was under anesthesia. The excised parotid gland 
tissue was also kept after surgery. Cytopathological and Histopathological examinations 
were performed by different pathologists to avoid bias. The diagnoses of the two in the 
same specimen was evaluated for accuracy. In this case histopathology was considered the 
gold standard and therefore became the control. 
  
If the correlation between FNAC and Histopathology was significant then a cytopathological 
preoperative diagnosis can start the initial treatment of patients with parotid gland tumours 
and it can influence the management of patients with parotid gland tumours to avoid excess 
morbidity associated with over treatment of parotid gland tumours. The general objective of 
this study was to determine the correlation of FNAC and histopathology in the diagnosis of 
parotid tumors at University Teaching Hospital in Lusaka, Chipata Central Hospital in 
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Chipata, Livingstone Central Hospital in Livingstone and Ndola Teaching Hospital in Ndola, 
Zambia. The specific objectives were to determine the specificity and sensitivity of FNAC; 
and calculate the positive and negative predicitive values, and likelihood ratio of FNAC in the 
diagnosis of Parotid Tumours; and to determine the usefulness of FNAC in the management 
of Parotid tumours.                 
 
Patients and Methods 
 
This was a prospective study done in the Departments of Surgery at the University Teaching 
Hospital (Lusaka), Ndola Teaching Hospital (Ndola), Chipata Central Hospital (Chipata) and 
Livingstone Central Hospital (Livingstone); from April 2014 to October 2016. A total of 25 
patients with parotid tumours were recruited in this study and all were later operated. All 
the 25 patients were subjected to thorough history and physical examination with 
appropriate imaging. A preoperative FNAC was done either in the clinic, on the ward or just 
before operation under General anesthesia in theatre depending on patients’ preferences. 
The postoperative excision samples were submitted for histopathological diagnosis.   
 
FNAC was done using a 10cc syringe and a 20-22G needle in a patient who had given an 
informed consent. The smears were done on 6 glass slides, 3 were fixed in alcohol and 3 
were air dried, then stained with papanicolaou stains, subsequently reported. The post-
operative excision samples were fixed in 10% formalin and then gross and microscopic 
examinations performed after staining with H&E stains. The FNAC and Histopathology 
reports were then retrospectively reviewed, compared and analyzed.  A comparison of 
preoperative FNAC and post-operative histopathology diagnosis was done and the data 
analysis was performed by calculating the sensitivity and specificity, likelihood ratio and 




The study population was comprised of 25 patients who had had preoperative samples 
collected for FNAC and had a final Histological post-operative diagnosis. Eleven were males 
and 14 were females giving a male to female sex ratio of 1: 1.3. Their ages ranged from 19 
to 74 years with a mean of 40.6 years and a median age of 34 years.  
 
Figure 1 shows the age distribution of patients in the study. Figure 2 shows the diagnoses 
made on histopathology. Commonest tumour was pleomorphic adenoma at 52%. 
 
FNAC did not correlate with 3 specimens which were diagnosed as 1 chronic sialadenitis 
(wrong diagnosis, histopathology showed invasive squamous cell carcinoma); and 2 samples 
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Table 1. The FNAC and Histological diagnoses of the patients involved in the study. 
 




1 F 35 Pleomorphic adenoma Pleomorphic adenoma TP  
2 M 29 lymphocytes/acini/ 
myoepithelial Cells 
lymphoepithelial Cyst TP  
3 F 19 lymphocytes/acini/ 
myoepithelial Cells 
lymphoepithelial Cyst TP  
4 M 44 Acellular/unsatisfactor
y 
lymphoepithelial Cyst  FN 
5 F 68 Pleomorphic adenoma Pleomorphic adenoma TP  
6 F 29 Carcinoma Epithelial-myoepithelial 
carcinoma 
TP  
7 F 34 Acellular/unsatisfactor
y 
lymphoepithelial Cyst  FN 
8 F 45 Pleomorphic adenoma Pleomorphic adenoma TP  
9 F 35 Pleomorphic adenoma Pleomorphic adenoma TP  
10 F 15 Pleomorphic adenoma Pleomorphic adenoma TP  
11 F 84 Pleomorphic adenoma Pleomorphic adenoma TP  
12 F 22 Pleomorphic adenoma Pleomorphic adenoma TP  
13 M 28 Pleomorphic adenoma Pleomorphic adenoma TP  
14 M 30 Pleomorphic adenoma Pleomorphic adenoma TP  
15 M 68 Carcinoma Invasive SCC TP  
16 M 28 lymphocytes/acini/ 
myoepithelial Cells 
lymphoepithelial Cyst TP  
17 M 56 Carcinoma Invasive SSC Metastatic TP  
18 F 40 lymphocytes/acini/ 
myoepithelial Cells 
lymphoepithelial Cyst TP  
19 M 71 Carcinoma Invasive SCC TP  
20 F 74 Carcinoma Invasive SCC TP  
21 F 31 Pleomorphic adenoma Pleomorphic adenoma TP  
22 M 23 Pleomorphic adenoma Pleomorphic adenoma TP  
23 M 19 Pleomorphic adenoma Pleomorphic adenoma TP  
24 F 19 Pleomorphic adenoma Pleomorphic adenoma TP  
25 M 69 Chronic Sialadenitis metastatic carcinoma  FN 
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Table 2. Analysis of non-neoplastic and neoplastic tumours in the study. 
 





   
Benign Lesions      
Pleomorphic 
adenoma 
13 13    
lymphoepithelial Cyst 6 4 (2 samples where 
acellular) 
 0.76 0.68    
Malignant lesions      
Carcinoma 6 5    
 0.24 0.2    
Non- Neoplastic      
chronic sialadenitis 0 1 (wrong 
diagnosis) 
 




































































Figure 3. Histological diagnosisFigure 2. Histological Diagnosis 
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Table 3. 
 TRUE FALSE 
Positive 22 (a) 1 (b) 
Negative 0 © 2 (d) 
 
Calculations 
Sensitivity =  a/(a+c) 
  22/(22+0) 




  2/(1+2) 
  2/3 
  0.6667 (66.7%) 
 
Positive predictive value= a/(a+b) 
    22/(22+1) 
    22/23 
    0.9565 (95.7%) 
 
Negative Predicative value= d/(c+d) 
    2/(0+2) 
    2/2 
1.0 (100%) 
Likelihood ratio= sensitivity/ (1-specifity) 
   1.00/(1-0.667) 
   1.00/.3333 
   3.003 
   3 
The study showed that FNAC has a sensitivity of 100% and specificity of 66.7%. The Positive 
Predictive value was 95.7% and the Negative Predictive value was 100%. The Likelihood 




FNAC is a safe, cheap and cost effective preoperative diagnostic procedure for assessment 
of Parotid tumours that offers a cytological diagnosis important in influencing management 
of Parotid tumours4,6. The management of parotid tumours involves an assessment of 
whether the Parotid tumour is inflammatory or neoplastic, and If neoplastic then whether 
benign or malignant. Inflammatory lesions are management conservatively while neoplastic 
tumours are subjected to surgery.4 
 
Benign tumours of the Parotid gland in the superficial lobe are treated with superficial 
parotidectomy while those in the deep lobe are treated with total parotidectomy with facial 
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nerve excision, while in some centres facial nerve sparing surgery is performed. Malignant 
tumours are treated with total parotidectomy with facial nerve excision4. Some centres 
perform superficial parotidectomies for malignant tumours in the superficial lobe with facial 
nerve sparing. All FNACs in the study were collected preoperatively few minutes or hours 
before the scheduled operations based on clinical assessment. All patients in the study had 
superficial parotidectomy with facial nerve sparing.  
 
In this study, 88% of the samples from parotid tumours where diagnosed as neoplastic 
parotid tumours and 12% where unsatisfactory/acellular (2 out of 25) and wrong diagnosis 
(1 out of 25) on FNAC; while histology diagnosed 100% as neoplastic parotid tumours.  FNAC 
diagnosed 68% as benign parotid tumours and 20% as malignant parotid tumours. 
Histopathology diagnosed 76% as benign parotid tumours and 24% as malignant parotid 
tumours. This finding is comparable with what other authors have found and reported 
benign tumours at 40%, 61% and 69%; while malignant tumours have been reported at 6%, 
13% and 37%. The commonest benign parotid tumour was pleomorphic adenoma at 52% on 
FNAC and Histopathology. FNAC was unable to characterize the malignant tumours and 
therefore reported as carcinoma but Histopathology showed Invasive squamous cell 
carcinoma as commonest malignant tumor of the parotid. 
 
The age range was from 15 to 84 years. This shows that parotid tumours affects all age 
groups. Parotid tumours were seen more commonly in females than in males with a female 
to male ration of 1.2:1. Other studies have reported a ratio of 1.8:1 (F:M) ratio4. 
Pleomorphic adenoma was more common in females than in males at 69.2% of all 
pleomorphic adenomas. Carcinomas were more common in males than in females at 66.7% 
of all carcinomas in the study. 
 
Two samples were acellular/unsatisfactory because of the cystic nature of the parotid 
tumours and therefore difficult to harvest any cells on aspiration. This phenomenon has 
been described by some authors and therefore a known weakness of FNAC4,6. Sometimes 
technique becomes important in ensuring proper sample collection otherwise the results 
maybe unsatisfactory necessitating repeating the procedure or the result maybe wrong 
altogether as was seen in one of the samples that showed chronic sialadenitis on FNAC but 
histopathology showed metastatic carcinoma. Sample collection on FNAC harvested 
necrotic tissue and inflammatory cells hence missing the diagnosis. This raises concern that 
FNAC requires proper technique of sample collection to ensure proper specimen that is 
representative of the tumour is collected. In this study, the sensitivity of FNAC was 100% 
while specificity was 66.7%. Other authors have reported 57-98% sensitivity and specificity 
of 86-100%4,6. The findings in this study are therefore comparable. The positive and negative 
predictive values were 95.7% and 100% respectively. This is very significant. The likelihood 
ratio was 3.03 which is very significant for the application of FNAC as a diagnostic test at the 
four centres were the study was conducted. The likelihood ratio of 3 increases the pretest 
probability that the positive result of FNAC will more likely indicate a correct pathology in 
the parotid gland of the patient and can therefore be adopted as an evaluation tool for 
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This study has shown that FNAC correlates with histopathology and therefore can be 
provide a preoperative cytological diagnosis which can influence management of patients 
parotid tumours in terms of whether to operate or not, and If a patient should be operated 
then what would be the extent of surgery and would the facial nerve be spared or not. 
Some patients in this study will have recurrences and therefore increased morbidity of 
reoperations for malignant tumours. This practice could be avoided in future by adopting 
preoperative cytological diagnosis of parotid tumours with FNAC. This shows that clinical 
assessment alone is not sufficient to evaluate parotid tumours and decide the extent of 
surgery. This study has shown the usefulness of FNAC and its potential to influence 
management of parotid tumours. The preoperative cytological diagnosis can guide the 
extent of surgery to be done and whether the facial nerve should be excised or spared. 
However, it has been shown that FNAC cannot give definitive diagnoses of some Parotid 
tumours compared to histopathology or but can determine whether the tumour is 
neoplastic or inflammatory and if neoplastic whether benign or malignant4.   
 Conclusion 
 
This study has demonstrated that FNAC correlates with histopathology in the diagnosis of 
parotid tumours. FNAC is highly sensitive (100%) and specific (66.7%) and its usefulness as a 
cheap, cost effective, safe procedure in the evaluation of Parotid tumours has been 
demonstrated and that it can be relied upon to influence management of Parotid tumours. 
FNAC is therefore more reliable than clinical examination in distinguishing between 




FNAC should be adopted as a preoperative assessment procedure of evaluating Parotid 
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